Initial Results From First Patient Dosed With Perspective

Initial Results From First Patient Dosed With Perspective

The result from first patient dosed with VMT-α-NET in India on a compassionate use basis showed favorable responses. The initial response was measured by a......

Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce

Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce

Company’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies New corporate tagline and......

menu
menu